Mark A Lovich Selected Research

sacubitril

11/2019	Interaction Between Sacubitril and Valsartan in Preventing Heart Failure Induced by Aortic Valve Insufficiency in Rats.
1/2019	Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure.
11/2018	A Novel Paradigm for Sacubitril/Valsartan: Beta-Endorphin Elevation as a Contributor to Exercise Tolerance Improvement in Rats With Preexisting Heart Failure Induced by Pressure Overload.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Lovich Research Topics

Disease

3	Heart Failure 11/2019 - 11/2018
2	Fibrosis (Cirrhosis) 11/2019 - 01/2019
2	Pulmonary Hypertension 02/2014 - 05/2011
1	Critical Illness (Critically Ill) 05/2022
1	Aortic Valve Insufficiency (Aortic Regurgitation) 11/2019
1	Left Ventricular Dysfunction 11/2018
1	Tachycardia (Tachyarrhythmias) 09/2015

Drug/Important Bio-Agent (IBA)

3	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2019 - 11/2018
3	sacubitrilIBA 11/2019 - 11/2018
3	Valsartan (Vals)FDA Link 11/2019 - 11/2018
3	Neprilysin (Neutral Endopeptidase)IBA 11/2019 - 11/2018
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2019 - 11/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2014 - 05/2011
1	beta-Endorphin (Endorphin, beta)IBA 11/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 09/2015
1	Biological ProductsIBA 02/2014
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2011
1	Oxygen (Dioxygen)IBA 05/2011
1	Nitrogen DioxideIBA 05/2011

Therapy/Procedure

3	Therapeutics 11/2019 - 11/2018
1	Intravenous Infusions 05/2022